RSC Chemical BiologyPub Date : 2026-08-12eCollection Date: 2026-10-08DOI: 10.1039/d6cb00161k
Wai-Lun Chan, Alexander A Vinogradov
{"title":"ΔAlaAz cleavable linkers: efficient peptide cleavage in the presence of aromatic thiols and air oxygen.","authors":"Wai-Lun Chan, Alexander A Vinogradov","doi":"10.1039/d6cb00161k","DOIUrl":"10.1039/d6cb00161k","url":null,"abstract":"<p><p>Selective disassembly of multifunctional molecules through the use of cleavable linkers is central to many aspects of chemical biology, biochemistry, and pharmaceutical science. Ideally, cleavable linkers are structurally small and chemically stable on their own but fragment rapidly in the presence of a specific trigger without damaging the rest of the molecule. Here, we report the discovery of the facile oxidative cleavage of 2-(1-amidovinyl)azole-containing peptides (ΔAlaAz; Az: thiazole or oxazole) in the presence of aromatic thiols and air oxygen under ambient conditions. The reaction leads to quantitative peptide cleavage in minutes (<5 min for some substrates) in aqueous buffers at room temperature. We demonstrate that the ΔAlaAz cleavable linkers can be utilized to (i) linearize complex cyclic peptides, (ii) aid the structure determination of ΔAlaAz-containing natural products, and (iii) facilitate the isolation of peptides from cell lysates. Altogether, our work adds an efficient method to the toolbox of cleavable linkers in chemical biology.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"2028-2039"},"PeriodicalIF":3.9,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13480372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148798948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RSC Chemical BiologyPub Date : 2026-08-11eCollection Date: 2026-10-08DOI: 10.1039/d6cb00121a
László Petri, Írisz K Kovács, Blanka J Kiss, György M Keserű
{"title":"Disulfide rebridging platforms for site-specific ADC conjugation.","authors":"László Petri, Írisz K Kovács, Blanka J Kiss, György M Keserű","doi":"10.1039/d6cb00121a","DOIUrl":"10.1039/d6cb00121a","url":null,"abstract":"<p><p>Antibody-drug conjugates (ADCs) have emerged as a transformative class of targeted therapeutics, combining the exquisite specificity of monoclonal antibodies with the potency of small-molecule cytotoxic payloads. While numerous strategies exist to generate ADCs, site-specific conjugation methods have gained prominence due to their ability to produce homogeneous constructs with defined drug-antibody ratios, improved stability, and predictable pharmacokinetics. Among these, disulfide rebridging chemistries have recently attracted considerable attention as an elegant and versatile platform for precise antibody modification. By exploiting native interchain disulfide bonds, rebridging approaches restore structural integrity while introducing functional handles for payload attachment, enabling the generation of reproducible and structurally well-defined ADCs from native antibodies. This review provides a systematic and comprehensive overview of the chemical methodologies developed for disulfide rebridging, tracing the evolution of rebridging reagents and strategies from early maleimide and bissulfone scaffolds to modern dibromopyridazinediones, and other bridging frameworks. Beyond chemistry, we discuss the biological implications of rebridged ADCs, including their translational potential, supported by emerging preclinical and clinical data. Providing a dual chemical and biological perspective, this review aims to serve as a practical guide for researchers seeking to navigate the expanding landscape of site-specific ADC development, ultimately contributing to the rational design of next-generation targeted therapeutics.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"1943-1957"},"PeriodicalIF":3.9,"publicationDate":"2026-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13482864/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148799020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RSC Chemical BiologyPub Date : 2026-08-10eCollection Date: 2026-10-08DOI: 10.1039/d6cb00092d
Bob van Puffelen, Leandro Xavier Neves, Roy Steneker, Nico J Meeuwenoord, Edward Emmott, Dmitri V Filippov
{"title":"Synthesis of a guanylylated peptide derived from norovirus VPg as a molecular tool for studying norovirus replication.","authors":"Bob van Puffelen, Leandro Xavier Neves, Roy Steneker, Nico J Meeuwenoord, Edward Emmott, Dmitri V Filippov","doi":"10.1039/d6cb00092d","DOIUrl":"10.1039/d6cb00092d","url":null,"abstract":"<p><p>Norovirus is a leading cause of global acute gastroenteritis, yet the mechanisms underlying its replication remain incompletely understood. As a positive-sense single-stranded RNA (+ ssRNA) virus, norovirus utilizes a nucleotidylated viral protein (VPg) as a primer for synthesis of its genomic and subgenomic mRNAs. In this study, we report the efficient solid-phase synthesis of a guanylylated (also known as GMPylated) VPg-derived peptide fragment using a novel pre-guanylylated tyrosine building block equipped with acid-sensitive protecting groups. This approach enables a streamlined, one-step deprotection and cleavage process. The resulting synthetic peptide was characterised <i>via</i> LC-MS/MS, establishing its gas-phase fragmentation behaviour and confirming prior observations of a diagnostic guanine nucleobase peak at 152.0572 <i>m</i>/<i>z</i>. We subsequently applied these findings to develop a parallel reaction monitoring (PRM) assay to investigate endogenous VPg guanylylation in murine microglial cells infected with murine norovirus (MNV). Our results demonstrate that while unmodified VPg is detectable from 4 hours post-infection, the guanylylated form appears predominantly during later stages (8-12 hpi). The timing of VPg guanylylation is consistent with a model where guanylylation may serve as a regulator in the switch between anti-sense and sense RNA synthesis, though at this time this hypothesis is speculative and remains to be proven. These synthetic molecular tools and mass spectrometry assays provide a robust framework for further exploring the role of nucleotidylation in viral pathogenesis and in broader cell and pathogen biology.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"1978-1985"},"PeriodicalIF":3.9,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13485141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148798950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RSC Chemical BiologyPub Date : 2026-08-08eCollection Date: 2026-10-08DOI: 10.1039/d6cb00037a
Hayden Tobias, Sarah Porter, Isabella Marcelo, Abigail Koons, Soren C Spina, Courtney Culkins, Blaise R Kimmel
{"title":"Current landscape of RNA chemistry and delivery in cancer immunotherapy.","authors":"Hayden Tobias, Sarah Porter, Isabella Marcelo, Abigail Koons, Soren C Spina, Courtney Culkins, Blaise R Kimmel","doi":"10.1039/d6cb00037a","DOIUrl":"10.1039/d6cb00037a","url":null,"abstract":"<p><p>Small interfering RNAs (siRNAs) are programmable nucleic acids that play key roles in chemical biology and can selectively silence disease-associated genes through RNA interference (RNAi). These programmable nucleic acids have emerged as a powerful class of medicines and chemical biology tools that can rewire tumor-immune signaling, target immunosuppressive genes, stimulate immune responses, and boost the immune system against immune-mediated diseases. Recent success in the rapid synthesis and applications of siRNA highlights the potential of this technology to address previously \"undruggable\" targets across a range of genetic, metabolic, and oncologic diseases. Despite the potential of these siRNA-based therapies, including those used in cancer immunotherapy, challenges such as off-target effects during delivery, chemical degradation of siRNA in the body, and immunogenicity limit their efficacy. This review provides a comprehensive overview of the chemical biology and chemical modifications inherent to the design of robust siRNA therapies; the nucleic acid structure-function relationships that dictate the cellular mechanisms underlying siRNA-mediated gene silencing and efficacy; and the current clinical landscape and safety of approved siRNA therapeutics for immunotherapy. We examine the growing role of computationally guided design strategies and emerging machine-learning-based methods in optimizing siRNA chemical design, and outline how recent advances in siRNA chemical modification are expected to improve targeted gene modulation in the clinic. Additionally, we examine the role of delivery systems in enhancing siRNA potency, with an emphasis on tumor-targeted and tissue-specific approaches, as well as emerging combination therapies integrating siRNA with chemotherapy, immune checkpoint blockade, siRNA and mRNA co-delivery, and prodrug activation.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"1897-1920"},"PeriodicalIF":3.9,"publicationDate":"2026-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13464625/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148723052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RSC Chemical BiologyPub Date : 2026-08-07eCollection Date: 2026-09-02DOI: 10.1039/d6cb00043f
Jennifer Shyong, Clay C C Wang
{"title":"Activation of secondary metabolism in <i>Aspergillus</i> and related filamentous fungi through regulatory engineering.","authors":"Jennifer Shyong, Clay C C Wang","doi":"10.1039/d6cb00043f","DOIUrl":"10.1039/d6cb00043f","url":null,"abstract":"<p><p>Filamentous fungi are major contributors to diverse secondary metabolites with broad applications to medicine, agriculture, and biotechnology. Advances in genome sequencing and bioinformatic tools have revealed that fungal genomes encode far more biosynthetic gene clusters (BGCs) than are expressed under normal laboratory conditions, leaving much biosynthetic potential transcriptionally silent. Overcoming this gap between predicted and observed secondary metabolism has become a major challenge in fungal natural product discovery. In this review, we summarize current strategies for activating silent or weakly expressed fungal BGCs through regulatory engineering, with an emphasis on approaches validated in <i>Aspergillus</i>, <i>Penicillium</i>, <i>Monascus</i>, and related filamentous fungi. We focus on genetic and chemical manipulations that enable coordinated activation of multiple biosynthetic pathways through chromatin-level modifiers, global transcriptional regulators, and developmental regulators. By framing these regulators as practical tools rather than solely biological components, we demonstrate their strengths, limitations, and applications in <i>Aspergillus</i> and related filamentous fungi. We further discuss emerging combinatorial and integrative approaches that use regulatory engineering alongside omics technologies and predictive tools, outlining alternatives and future directions for improving the interpretability of silent pathway activation.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"1669-1686"},"PeriodicalIF":3.9,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13474000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148765870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RSC Chemical BiologyPub Date : 2026-07-28eCollection Date: 2026-09-02DOI: 10.1039/d6cb00128a
Joel Tong, Isuru M Jayalath, James V Parsons, Ju-An Kim, Matthew D Mann, Michal Tokmina-Roszyk, Thomas Kodadek
{"title":"Discovery of low molecular weight protein-binding fragments from bead-displayed libraries: application to monomeric proteins.","authors":"Joel Tong, Isuru M Jayalath, James V Parsons, Ju-An Kim, Matthew D Mann, Michal Tokmina-Roszyk, Thomas Kodadek","doi":"10.1039/d6cb00128a","DOIUrl":"10.1039/d6cb00128a","url":null,"abstract":"<p><p>Fragment-based drug discovery (FBDD) is a powerful workflow for the development of drug candidates and probe molecules that begins with the discovery of one or more low affinity, low molecular weight ligands for a protein of interest (POI). Recently, we developed a simple fragment discovery platform in which TentaGel beads displaying many copies of the fragment are incubated with a fluorescently labeled multimeric protein. Association of two or more bead-displayed ligands with the multimeric target stabilizes the complex sufficiently to allow its detection even after rigorous washing. However, this simple \"pull-down\" assay cannot be used for monomeric protein targets since these complexes are too kinetically labile to survive being taken out of equilibrium. Here we explore various strategies to multimerize monomeric targets, thus allowing them to be used as targets in this fragment discovery platform. We find that a particularly effective and convenient strategy is to express a fusion of the POI with FOLDON, a 30-residue, homo-trimeric peptide.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"1828-1838"},"PeriodicalIF":3.9,"publicationDate":"2026-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13439615/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148680349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RSC Chemical BiologyPub Date : 2026-07-27eCollection Date: 2026-10-08DOI: 10.1039/d6cb00144k
Allison E Batka, Aneesh Bhat, Alexander J Rose, Michael A Marletta
{"title":"Participation of redox-active residues in polysaccharide monooxygenase catalysis.","authors":"Allison E Batka, Aneesh Bhat, Alexander J Rose, Michael A Marletta","doi":"10.1039/d6cb00144k","DOIUrl":"10.1039/d6cb00144k","url":null,"abstract":"<p><p>Polysaccharide monooxygenases (PMOs) degrade carbohydrate polymers <i>via</i> an oxidative mechanism involving activation of O<sub>2</sub> or H<sub>2</sub>O<sub>2</sub> at a mononuclear copper active site. The reaction with O<sub>2</sub> requires the timely delivery of two electrons to the copper during each catalytic cycle. Large polymeric substrates might occlude the active site from reductant access, which raises questions of whether the substrate stays associated with the PMO during catalysis and whether there is an alternate path for electrons to reach the active site. Previous work provided evidence for electron transfer through residues Y168 (the axial tyrosine) and Y62 in an AA9 PMO, <i>Mt</i>PMO9E. Results reported here further investigate these redox-active residues by comparing the Y62F/Y168F double variant (2F) to the wild-type (WT) enzyme. Oxidase activity and oxygenase activity were compared using three different reductants: cysteine, ascorbate, and cellobiose dehydrogenase. Unlike cysteine and ascorbate, cellobiose dehydrogenase is comparatively large and thought to be the native electron donor to fungal PMOs. The oxidase and oxygenase activities of 2F are significantly decreased compared to WT, but the peroxygenase activity is unaffected. The slow oxygenase activity of 2F suggests the PMO is preferentially reduced <i>via</i> the redox-active residues, although some reduction may occur directly at the active site when the substrate is present. Engineering tyrosine residues into an AA9 PMO that natively lacks the redox-active residues increases oxidase activity. The oxygenase reaction is first-order in the reductant, suggesting the rate-limiting step involves electron transfer between the reductant and the redox-active residues. These observations underscore the importance of redox-active residues in O<sub>2</sub> utilization by PMOs.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"2069-2079"},"PeriodicalIF":3.9,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13462859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148722223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RSC Chemical BiologyPub Date : 2026-07-27eCollection Date: 2026-09-02DOI: 10.1039/d6cb00166a
Zhijian Yan, Wei Qin
{"title":"Non-specific cysteine modifications on proteins induced by <i>trans</i>-cyclooctene.","authors":"Zhijian Yan, Wei Qin","doi":"10.1039/d6cb00166a","DOIUrl":"10.1039/d6cb00166a","url":null,"abstract":"<p><p>Tetrazine-<i>trans</i>-cyclooctene (Tz-TCO) click chemistry has been widely adopted for various applications due to its faster reaction kinetics and higher biocompatibility compared to conventional copper-catalyzed click chemistry. However, most click chemistry groups do not appear to be fully bioorthogonal, as several of them-including tetrazine-have been found to directly modify proteins. Here, we report the unexpected discovery of non-specific protein modifications by TCO during the development of a tetrazine-based proximity labeling method. TCO probes readily conjugate to cysteine residues on proteins, and pre-treatment with iodoacetamide significantly reduces TCO-mediated background labeling. Chemoproteomic analyses reveal that proteins involved in translation are heavily modified by TCO, pointing to potential off-target effects when TCO probes are used in live cells. Our findings underscore the need for further improving the biocompatibility of click chemistry to enable more precise biological applications.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"1724-1729"},"PeriodicalIF":3.9,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13455793/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148707891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RSC Chemical BiologyPub Date : 2026-07-21eCollection Date: 2026-09-02DOI: 10.1039/d6cb00065g
Amrita Date, Archie Wall, Hannah Kiely-Collins, Theo Flack, Jack W Houghton, Jianan Lu, Adam M Thomas, Peiyu Zhang, Andrew J Wilson, Edward W Tate, Anna Barnard
{"title":"Proteome-wide target profiling of α-helix mimetics.","authors":"Amrita Date, Archie Wall, Hannah Kiely-Collins, Theo Flack, Jack W Houghton, Jianan Lu, Adam M Thomas, Peiyu Zhang, Andrew J Wilson, Edward W Tate, Anna Barnard","doi":"10.1039/d6cb00065g","DOIUrl":"10.1039/d6cb00065g","url":null,"abstract":"<p><p>The dysregulation of protein-protein interactions (PPIs) in disease states is well established, yet they are challenging to target, owing to the large surface area and featureless nature of protein binding interfaces. For targeting helix-mediated interactions, α-helix mimetics present a promising strategy. These are versatile small molecule scaffolds, capable of mimicking the hotspot residues on an α-helix. A wide range of such scaffolds have been reported, yet their target protein selectivity in the context of a whole proteome requires further exploration. Here, we report the affinity-based protein profiling of three structurally distinct classes of α-helix mimetics, <i>N</i>-substituted oligobenzamides, pyrrolopyrimidines, and oxopiperazines. This represents the first direct cross-comparison of different helix mimetic scaffolds, revealing significant differences in proteome-wide selectivity.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"1818-1827"},"PeriodicalIF":3.9,"publicationDate":"2026-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13417162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148621789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RSC Chemical BiologyPub Date : 2026-07-20eCollection Date: 2026-09-02DOI: 10.1039/d6cb00146g
Caroline M Donaghy, Helena V Heyer-Gray, Charlotte O'Hern, Michael Ibrahim, Bryant Perez-Torres, Nichali Bogues, Andrei T Alexandrescu, Karrera Y Djoko, Jonathan L Klassen, Alfredo M Angeles-Boza
{"title":"Ant abaecin-2 is a context-dependent copper-binding effector that can be either inhibitory or protective.","authors":"Caroline M Donaghy, Helena V Heyer-Gray, Charlotte O'Hern, Michael Ibrahim, Bryant Perez-Torres, Nichali Bogues, Andrei T Alexandrescu, Karrera Y Djoko, Jonathan L Klassen, Alfredo M Angeles-Boza","doi":"10.1039/d6cb00146g","DOIUrl":"10.1039/d6cb00146g","url":null,"abstract":"<p><p>Host defense peptides (HDPs) are important components of the innate immune system that are used to combat pathogens and often rely on binding trace nutrient metals for their function. However, controlling nutrient metals may have other roles in host-symbiont interactions beyond poisoning harmful pathogens. This study characterizes the evolution, structural properties, and biochemical activity of the novel hymenopteran HDP abaecin-2. In myrmicine ants such as the fungus-growing tribe Attini, abaecin-2 has evolved to include an Amino-Terminal Cu(ii) and Ni(ii)-binding (ATCUN) motif, which we hypothesize binds copper, a trace nutrient that is enriched in attine ant colonies. Combined results from mass spectrometry, competitive binding assays, circular dichroism, and NMR indicate that the abaecin-2 peptide lacks a defined secondary structure and can associate with up to 2 Cu(ii) ions, one strongly bound at the ATCUN motif and another weakly bound, likely at a conserved histidine residue. Despite its copper-binding activity, abaecin-2 alone does not exhibit antibacterial activity against <i>Escherichia coli</i> or <i>Bacillus subtilis</i> (models for bacteria that live in ant fungus gardens). However, it synergizes with a model pore-forming peptide cecropin A to inhibit the growth of <i>E. coli</i>, similar to the related peptide abaecin-1. The copper-binding activity conferred by the ATCUN motif also protects copper-sensitive <i>E. coli</i> from excess copper toxicity. The dual context-dependent inhibitory and protective roles for abaecin-2 indicate that this previously under-characterized HDP may be used by attine ants to regulate both harmful and beneficial symbionts.</p>","PeriodicalId":40691,"journal":{"name":"RSC Chemical Biology","volume":" ","pages":"1804-1817"},"PeriodicalIF":3.9,"publicationDate":"2026-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13398410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148585502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}